Vivani Medical, Inc.
VANI
$0.9351
-$0.0549-5.55%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -18.39% | -1.68% | 45.35% | 86.51% | 137.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.96% | 0.52% | 19.66% | 38.08% | 58.00% |
| Operating Income | 8.96% | -0.52% | -19.66% | -38.08% | -58.00% |
| Income Before Tax | 12.81% | -29.39% | -55.83% | -84.71% | -163.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.81% | -29.39% | -55.83% | -84.71% | -163.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.81% | -29.39% | -55.83% | -84.71% | -163.20% |
| EBIT | 8.96% | -0.52% | -19.66% | -38.08% | -58.00% |
| EBITDA | 9.23% | -0.65% | -20.29% | -38.97% | -59.15% |
| EPS Basic | 22.64% | -16.59% | -30.04% | -38.87% | -98.57% |
| Normalized Basic EPS | 16.38% | 13.47% | 4.59% | -0.57% | -12.59% |
| EPS Diluted | 22.64% | -16.59% | -30.04% | -38.87% | -98.57% |
| Normalized Diluted EPS | 16.38% | 13.16% | 4.23% | -0.96% | -13.05% |
| Average Basic Shares Outstanding | 11.07% | 16.58% | 23.84% | 34.28% | 31.92% |
| Average Diluted Shares Outstanding | 11.07% | 16.25% | 23.45% | 33.83% | 31.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
